Biopharmaceutical company that designs and develops biologics for pulmonary hypertension & musculoskeletal disorders.

Biotechnology

Life Sciences

35Pharma

Ilia A. Tikhomirov

Dan Chiche

Dmitry Tikhomirov

Maureen O’connor

George Georges

Thomas P. Loisel

Thomas Loisel

Julia Schoelermann

The Leadership Team at 35Pharma is responsible for steering the company's strategic direction, overseeing the development and manufacturing of biologics for pulmonary hypertension and musculoskeletal disorders. They ensure alignment across departments, drive key business initiatives, manage clinical operations, and foster corporate development to achieve the company's mission.

Leadership Team

The Clinical Operations team at 35Pharma is responsible for planning, executing, and overseeing clinical trials to ensure compliance with regulatory standards and achieve clinical objectives. They collaborate closely with cross-functional teams to manage timelines, budgets, and resources, ensuring the successful development and approval of biologics for pulmonary hypertension and musculoskeletal disorders.

Clinical Operations

The Research and Development team at 35Pharma spearheads the design and development of biologics targeting pulmonary hypertension and musculoskeletal disorders. Utilizing advanced machine learning and data analytics, preclinical studies, and translational research, they aim to innovate and expedite the discovery of effective therapeutic solutions.

35Pharma

Org chart

Teams

Leadership Team

Clinical Operations

Research and Development

Offices

35Pharma

Org chart

Teams

Leadership Team

Clinical Operations

Research and Development

Offices

Related companies